Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2026	Sep. 30, 2025	Sep. 30, 2026	Sep. 30, 2025
Operating expenses:
Research and development	$ 23,948	$ 20,012	$ 75,505	$ 62,914
General and administrative	19,421	5,981	36,426	16,987
Total operating expenses	43,369	25,993	111,931	79,901
Loss from operations	(43,369)	(25,993)	(111,931)	(79,901)
Other income (expense):
Interest income	1,093	419	3,139	843
Other income (expense), net	(33)	(5)	(204)	1,186
Total other income	1,060	414	2,935	2,029
Net loss	$ (42,309)	$ (25,579)	$ (108,996)	$ (77,872)
Net loss per share, basic (in usd per share)	$ (0.99)	$ (1.32)	$ (2.83)	$ (5.45)
Net loss per share, diluted (in usd per share)	$ (0.99)	$ (1.32)	$ (2.83)	$ (5.45)
Weighted-average common shares outstanding, basic (in shares)	42,797,370	19,389,776	38,508,964	14,281,149
Weighted-average common shares outstanding, diluted (in shares)	42,797,370	19,389,776	38,508,964	14,281,149